Residual disease after mastectomy - Authors' reply

Affiliations

¹ Head of Breast Cancer Radiation Therapy Unit, Sheba Medical Center, Ramat Gan, Israel; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, Netherlands.
² Department of Gynaecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Esslingen am Neckar, Germany.
³ Iridium Kankernetwerk, University of Antwerp, Antwerp, Belgium; Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. Electronic address: philip.poortmans@gza.be.

Comment

Orit Kaidar-Person et al. Lancet Oncol. 2020 Nov.

. 2020 Nov;21(11):e501.

doi: 10.1016/S1470-2045(20)30622-7.

¹ Head of Breast Cancer Radiation Therapy Unit, Sheba Medical Center, Ramat Gan, Israel; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, Netherlands.
² Department of Gynaecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Esslingen am Neckar, Germany.
³ Iridium Kankernetwerk, University of Antwerp, Antwerp, Belgium; Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. Electronic address: philip.poortmans@gza.be.

No abstract available

Comment on

Skip lesion of DIN (DCIS) in the nipple in a case of breast cancer.
Tramm T, Zuckerman K, Tavassoli FA. Tramm T, et al. Int J Surg Pathol. 2011 Dec;19(6):817-21. doi: 10.1177/1066896909339737. Epub 2009 Jul 3. Int J Surg Pathol. 2011. PMID: 19578048
Residual disease after mastectomy.
Bundred NJ, Dodwell D, Bundred JR, Cutress RI. Bundred NJ, et al. Lancet Oncol. 2020 Nov;21(11):e499. doi: 10.1016/S1470-2045(20)30542-8. Lancet Oncol. 2020. PMID: 33152291 No abstract available.
Residual disease after mastectomy.
Wu ZY, Han J, Eom JS, Ahn SH, Ko B. Wu ZY, et al. Lancet Oncol. 2020 Nov;21(11):e500. doi: 10.1016/S1470-2045(20)30526-X. Lancet Oncol. 2020. PMID: 33152292 No abstract available.